Biogen Pays $124 Million to Develop Gene-Based Therapies
Permalink

Biogen Pays $124 Million to Develop Gene-Based Therapies

“We expect this collaboration will further validate our novel adeno-associated virus (AAV) gene therapy platform…

Continue Reading →